Gensciences

Gensciences develops drugs that focus on underserved illnesses like hemophilia, metabolic diseases, and anti-tumor fields.

Last Funding Type: Series A
Industries: Biotechnology,Clinical Trials,Health Care,Pharmaceutical,Product Research
Founded date: Jan 1, 2019
Number Of Employee: 251 - 500
Operating Status: Active

Number of Funding Rounds

Total Funding Amount

2

—

Gensciences has raised a total of — in funding over 2 rounds. Their latest funding was raised on Mar 4, 2021 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Mar 4, 2021	Series A	—	1	—	—	Detail
Mar 4, 2021	Series B	—	1	Haitong Kaiyuan Investment	—	Detail

Number of Lead Investors

Number of Investors

1

2

Gensciences is funded by 2 investors. Haitong Kaiyuan Investment and Hygeia Capital LLC are the most recent investors.

Investor Name	Lead Investor	Funding Round
Haitong Kaiyuan Investment	Yes	Series B
Hygeia Capital LLC	—	Series A